What is Direxion Daily S&P Biotech Bear 3X ETF (LABD)?

Direxion Daily S&P Biotech Bear 3X ETF (LABD) is an ETF in the Financial Services sector, Asset Management - Leveraged industry. View full analysis on Stocks360.

What is the current price of LABD?

The current price of LABD is $6.75. Prices are updated in real time on Stocks360.

What is LABD's market capitalization?

LABD's market capitalization is $15,429,191.00, placing it in the small-cap tier.

Direxion Daily S&P Biotech Bear 3X ETF (LABD)

ETF analysis · AMEX · Financial Services · Asset Management - Leveraged

$6.75

Market Cap

$15.43M

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

-3.12

Day Range

$6.42 – $6.92

52-wk Range

$5.81 – $33.24

Avg Volume

N/A

Volume

23.09M

Direxion Daily S&P Biotech Bear 3X ETF (LABD) is an exchange-traded fund in the Financial Services sector. Latest price: $6.75. Market cap $15.43M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 15 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-30 · $28.64 2026-10-29 · $6.75 (-76.43%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Direxion Daily S&P Biotech Bear 3X ETF

The Direxion Daily S&P Biotech Bull and Bear 3X ETFs are designed to deliver daily investment returns reflecting triple (300%) the performance of the S&P Biotechnology Select Industry Index, or triple its inverse (opposite) performance, before factoring in any fees or expenses. It's important to note, however, that there is no assurance these funds will successfully achieve their intended daily objectives.